menu search

LABD / 5 Best Leveraged ETFs of Last Week

5 Best Leveraged ETFs of Last Week
Wall Street was upbeat last week. Abating banking crisis and a less-hawkish Fed led to the rally in Wall Street. Read More
Posted: Mar 27 2023, 09:11
Author Name: Zacks Investment Research
Views: 111624

LABD News  

LABU And LABD: Another Attractive Double-Short Pairs Trade

By Seeking Alpha
September 29, 2023

LABU And LABD: Another Attractive Double-Short Pairs Trade

Pairing Direxion Daily's S&P Biotech Bull 3X Shares ETF with their S&P Biotech Bear 3X Shares ETF produces a low volatility couple. Shorting both asse more_horizontal

LABD: 3X Leveraged Inverse Fund In Biotechnology Sector Is Best Avoided

By Seeking Alpha
July 21, 2023

LABD: 3X Leveraged Inverse Fund In Biotechnology Sector Is Best Avoided

Direxion Daily S&P Biotech Bear 3X Shares ETF failed to generate decent yield & price growth over the past 90 months. I don't foresee this fund genera more_horizontal

5 Best Leveraged ETFs of Last Week

By Zacks Investment Research
March 27, 2023

5 Best Leveraged ETFs of Last Week

Wall Street was upbeat last week. Abating banking crisis and a less-hawkish Fed led to the rally in Wall Street. more_horizontal

The Sell Rating Of LABD Is Reaffirmed

By Seeking Alpha
November 3, 2022

The Sell Rating Of LABD Is Reaffirmed

Since July 8 when I rated LABD a SELL, the underlying biotechnology index has moved very little up or down; LABD declined 25.22%. The biotechnology se more_horizontal

LABD: 3X Leveraged Investments Not Suitable For Long Term

By Seeking Alpha
March 18, 2022

LABD: 3X Leveraged Investments Not Suitable For Long Term

3X inverse derivative investments are extremely volatile and risky. more_horizontal


Search within

Pages Search Results: